Sign In
Last checked at 
20 Mar 2026 17:16
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.
THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE UK CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE").
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION
FOR IMMEDIATE RELEASE
20 March 2026
Statement regarding Spire Healthcare Group plc ("Spire Healthcare", the "Company")
Further to the announcement by Spire Healthcare on 18 February, Bridgepoint Advisers Limited ("Bridgepoint") confirms that it does not intend to make an offer for Spire Healthcare.
Bridgepoint is grateful for the efforts of the Spire Healthcare Board over the course of its participation in the Formal Sale Process, but Bridgepoint has been unable to get sufficient confidence as to a transaction structure that would work for all stakeholders at this time.
As a result of this announcement, Bridgepoint will, except with the consent of the UK Panel on Takeovers and Mergers (the "Panel"), be bound by the restrictions contained in Rule 2.8 of the Code.
For the purposes of Rule 2.8 of the Code, Bridgepoint reserve the right, either together or individually, to announce or participate in an offer or possible offer for Spire Healthcare and/or to take any other action which would otherwise be restricted under Rule 2.8 of the Code within 6 months after the date of this announcement in the following circumstances described in note 2 to Rule 2.8 of the Code: (i) with the consent of the Board of Spire Healthcare; (ii) if a third party announces a firm intention to make an offer for Spire Healthcare; (iii) if Spire Healthcare announces a Rule 9 waiver proposal (see Note 1 of the Notes on Dispensations from Rule 9) or a reverse takeover (as defined in the Code); or (iv) if the Panel determines there has been a material change of circumstances.
Enquiries:
Bridgepoint
Christian Jones +44 (0) 20 7034 3500
Nicole Gregory
Follow the stocks
